IPOs

Biotech IPOs: Outliers, Value Creation And The Dispersion Of Returns
Biotech IPOs: Outliers, Value Creation And The Dispersion Of Returns
Forbes
biotech
IPOs
Flag link:
Gene editing star CRISPR Therapeutics files for $90M IPO
Gene editing star CRISPR Therapeutics files for $90M IPO
Endpoints
gene editing
CRISPR Therapeutics
IPOs
Flag link:
Thar Pharmaceuticals hopes to raise $50M in IPO
Thar Pharmaceuticals hopes to raise $50M in IPO
BioPharma Dive
Thar Pharmaceuticals
IPOs
T121
Flag link:
AzurRx BioPharma Is An Ultra-High-Risk IPO
AzurRx BioPharma Is An Ultra-High-Risk IPO
Seeking Alpha
AzurRx BioPharma
IPOs
exocrine pancreatic insufficiency
Flag link:
inVentiv cancels IPO as it announces major investment from Advent
inVentiv cancels IPO as it announces major investment from Advent
Fierce Biotech
inVentiv
IPOs
Advent
Flag link:
From boom to swoon: Biotech IPOs fade fast in Q2
From boom to swoon: Biotech IPOs fade fast in Q2
Endpoints
biotech
IPOs
Flag link:
Advent, CVC bid for inVentiv ahead of IPO: sources
Advent, CVC bid for inVentiv ahead of IPO: sources
Reuters
inVentiv
Advent International
CVC
IPOs
M&A
Flag link:
Patheon guns for huge $625M IPO after major growth spurt
Patheon guns for huge $625M IPO after major growth spurt
Fierce Biotech
Patheon
IPOs
Flag link:
Despite sluggish IPO market, biotechs continue to lead the way
Despite sluggish IPO market, biotechs continue to lead the way
BioPharma Dive
IPOs
biotech
Reata Pharmaceuticals
Syros Pharmaceuticals
Flag link:
Polaris, Flagship, OrbiMed make it out with $70M IPO for Langer’s Selecta
Polaris, Flagship, OrbiMed make it out with $70M IPO for Langer’s Selecta
Fierce Biotech
IPOs
SEL-212
Selecta Biosciences
Flag link:
OrthoPediatrics registers $75m IPO
OrthoPediatrics registers $75m IPO
Mass Device
devices
OrthoPediatrics
IPOs
implants
pediatric
Flag link:
Sleep disorder device maker Oventus opens $12m down under IPO
Sleep disorder device maker Oventus opens $12m down under IPO
Mass Device
Oventus
IPOs
devices
sleep apnea
Australia
Flag link:
Biotech IPOs can be a crapshoot
Biotech IPOs can be a crapshoot
Marketwatch
biotech
IPOs
ProNai
Flag link:
U.S. IPO Week Ahead: Billionaire Doctor Back With Another IPO
U.S. IPO Week Ahead: Billionaire Doctor Back With Another IPO
Seeking Alpha
IPOs
NantHealth
Sensus Healthcare
Flag link:
Nasdaq Sees Israeli Biotech IPOs Tapping the Market This Year
Nasdaq Sees Israeli Biotech IPOs Tapping the Market This Year
Bloomberg
NASDAQ
biotech
Israel
IPOs
PolyPid
Kitov
Flag link:
Billionaire doctor to take another of his mysterious (and highly valued) companies public
Billionaire doctor to take another of his mysterious (and highly valued) companies public
Stat
Patrick Soon-Shiong
IPOs
NantHealth
bioinformatics
Flag link:
Diabetes 'Unicorn' Intarcia Hits Major Milestone
Diabetes 'Unicorn' Intarcia Hits Major Milestone
Fortune
Intarcia
diabetes
type 2 diabetes
IPOs
ITCA 650
Flag link:
CRISPR biotech Intellia strikes licensing deal with Regeneron, readies IPO
CRISPR biotech Intellia strikes licensing deal with Regeneron, readies IPO
BioPharma Dive
CRISPR
Intellia Therapeutics
Regeneron
IPOs
Flag link:
InVentiv Health files for IPO
InVentiv Health files for IPO
Medical Marketing and Media
inVentiv
IPOs
Flag link:
Week Ahead: Small-Cap Biotech IPO Kicks-Off Q2
Week Ahead: Small-Cap Biotech IPO Kicks-Off Q2
Seeking Alpha
biotech
IPOs
Aeglea BioTherapeutics
Flag link:

Pages